Hierridin B Isolated from a Marine Cyanobacterium Alters VDAC1, Mitochondrial Activity, and Cell Cycle Genes on HT-29 Colon Adenocarcinoma Cells by Freitas S. et al.
marine drugs 
Article
Hierridin B Isolated from a Marine Cyanobacterium
Alters VDAC1, Mitochondrial Activity, and Cell
Cycle Genes on HT-29 Colon Adenocarcinoma Cells
Sara Freitas 1, Rosário Martins 1,2,3,4, Margarida Costa 1, Pedro N. Leão 1, Rui Vitorino 5,6,
Vitor Vasconcelos 1,3 and Ralph Urbatzka 1,*
1 Interdisciplinary Center of Marine and Environmental Research (CIIMAR/CIMAR), University of Porto,
Rua dos Bragas 289, 4050-123 Porto, Portugal; freitas.srf.09@gmail.com (S.F.); mrm@estsp.ipp.pt (R.M.);
costa.anamarg@gmail.com (M.C.); pleao@ciimar.up.pt (P.N.L.); vmvascon@fc.up.pt (V.V.)
2 Health and Environmental Research Center (CISA), School of Apllied Health Sciences of Porto,
Polytechnic Porto, Rua Valente Perfeito 322, 4400-330 Vila Nova de Gaia, Portugal
3 Department of Biology, Faculty of Sciences, University of Porto, Rua do Campo Alegre, Edifício FC4,
4169-007 Porto, Portugal
4 Institute for Molecular and Cell Biology (IBMC), University of Porto, Rua do Campo Alegre 823,
4150-180 Porto, Portugal
5 Department of Medical Sciences, Institute of Biomedicine—iBiMED, University of Aveiro,
3810-193 Aveiro, Portugal; rvitorino@ua.pt
6 Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto,
4200-319 Porto, Portugal
* Correspondence: rurbatzka@ciimar.up.pt; Tel.: +351-223-401-818
Academic Editor: Keith B. Glaser
Received: 17 June 2016; Accepted: 24 August 2016; Published: 31 August 2016
Abstract: Background: Hierridin B was isolated from a marine cyanobacterium Cyanobium sp.
strain and induced cytotoxicity selectively in HT-29 adenocarcinoma cells. The underlying
molecular mechanism was not yet elucidated. Methods: HT-29 cells were exposed to the IC50
concentration of hierridin B (100.2 µM) for 48 h. Non-targeted proteomics was performed using
2D gel electrophoresis and MALDI-TOF/TOF mass spectrometry. The mRNA expression of
apoptotic and cell cycle genes were analyzed by real-time PCR. Automated quantification of
160 cytoplasm and mitochondrial parameter was done by fluorescence microscopy using CellProfiler
software. Results: Proteomics identified 21 significant different proteins, which belonged to protein
folding/synthesis and cell structure amongst others. Increase of VDAC1 protein responsible for
formation of mitochondrial channels was confirmed by mRNA expression. A 10-fold decrease of
cytoskeleton proteins (STMN1, TBCA) provided a link to alterations of the cell cycle. CCNB1 and
CCNE mRNA were decreased two-fold, and P21CIP increased 10-fold, indicative of cell cycle arrest.
Morphological analysis of mitochondrial parameter confirmed a reduced mitochondrial activity.
Conclusion: Hierridin B is a potential anticancer compound that targets mitochondrial activity
and function.
Keywords: natural products; bioactive compounds; anticancer drugs; colon cancer cells;
marine cyanobacteria; mitochondria; vdac1; cell cycle; proteomics; high content analysis
1. Introduction
Cancer is one of the leading causes of death in the world and the ability of resistance adaptation
towards many drug treatments and less toxic side effects requires the further development of
novel drugs [1]. Colon cancer causes high mortality worldwide arising from genetic mutations
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in gastrointestinal epithelial cells, altering its normal functioning and proliferation [2,3]. The incidence
of colorectal cancer is directly related with diet plans and overweight problems among populations,
due to the excessive presence of meat and alcohol in routine meals and lack of fruits and vegetables [4].
The marine environment is a prolific source of secondary active metabolites, which have been
isolated from organisms as sponges, tunicates, algae, and cyanobacteria [5,6]. Cyanobacteria are
an ancient group of photoautotrophic organisms and are known to produce anticancer,
anti-inflammatory, and antibacterial agents, among others [7–10]. Picocyanobacteria have been
described in recent years as a promising resource for the isolation and purification of compounds with
pharmacological activity, mainly as anti-cancer agents [11–13]. One example is hierridin B, a compound
produced by the picoplanktonic cyanobacterial strain Cyanobium sp. LEGE 06113, isolated from the
Portuguese coast by a bioassay-guided fractionation approach [14]. Hierridin B demonstrated a growth
inhibitor/cytotoxic effect selectively on the adenocarcinoma cell line HT-29 with an IC50 value of
100.2 µM; no cytotoxic effects were reported for other cancer cell lines as HEPG2, MG63, RKO,
SHSY5Y, SKBR3, T47D, or for normal prostate epithelium cells PNT2 [14]. Compounds isolated from
efficient phenotypic screening assays require searching for possible biological targets to characterize
the underlying mechanisms and altered pathways [15].
Consequently, the aim of the present study was to advance the knowledge regarding the
growth inhibitory/cytotoxic effect of hierridin B on the colon adenocarcinoma cell line HT-29.
Non-targeted proteomics was performed to gain insights into altered proteins, and the mRNA
expression of cell cycle and apoptosis genes were quantified. Since results pointed to an involvement
of mitochondrial proteins in the observed cytotoxicity, fluorescent microscopy analysis was




To analyze the selective cytotoxic mechanisms of hierridin B in the HT-29 cell line,
a non-targeted proteomic analysis was performed using two-dimensional gel electrophoresis
(2DGE). The analysis of 2DGE gels by the software PDQuest (BioRad, Hercules, CA, USA)
revealed differences between the solvent control group (dimethylsulfoxide, DMSO) and exposure
to hierridin B. Twenty-one significant spots were positively identified by matrix assisted laser
desorption/ionization-time of flight/time of flight (MALDI-TOF/TOF) mass spectrometry (Table 1),
while four different spots could not be identified. Network analyses (Figure 1) demonstrated the
connection between proteins involved in protein folding/protein synthesis (neutral alpha-glucosidase
AB, GANAB; calreticulin, CALR; t-complex protein 1 subunit delta, TCPD; elongation factor 2, EEF2)
to mitochondrial (voltage-dependent anion-selective channel protein 1, VDAC1) and cell structure
(gelsolin, GSN; t-complex protein 1 subunit delta, TCPD) proteins, which were linked to glycolysis
(alpha-enolase, ENO1) and pyrimidine biosynthesis (UMP-CMP kinase, CMPK1). Outside of the
predicted network based on known interaction of proteins, further cell structural proteins were
present (tubulin-specific chaperone A, TBCA; heat-shock protein beta-1, HSPB1; stathmin, STMN1),
as well as proteins for tumor survival (serine hydroxymethyl transferase, SHMT2), cell proliferation
(tumor protein D52, TPD52), or fatty acid metabolism (delta(3,5)-delta(2,4)-dienoyl-CoA
isomerase, ECH1).
Analysis of the biological processes confirmed the prevalence of “mitochondrial calcium ion
transport” and “regulation of mitophagy”, supported by VDAC1, whereas “‘de novo’ posttranslational
protein folding”, “positive regulation of DNA replication”, and “intrinsic apoptotic signaling pathway
in response to oxidative stress” were decreased by hierridin B treatment (Figure 2).
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Table 1. Significant regulated proteins of HT-29 cells exposed to hierridin B compared with the control group (DMSO).
SPP Protein Name DMSO(Mean ± SD)
Hierridin B





506 Calreticulin 3316 ± 504 1951 ± 172 0.6 CALR_HUMAN CALR 215 15 2
1513 Diablo homolog, mitochondria 717 ± 23 502 ± 12 0.7 DBLOH_HUMAN DIABLO 105 7 2
2602 Tumor protein D52 946 ± 96 633 ± 146 0.7 TPD52_HUMAN TPD52 133 8 2
2713 - 281 ± 80 76 ± 70 0.3 - - - - -
3101 Tubulin-specific chaperone A 730 ± 313 88 ± 18 0.1 TBCA_HUMAN TBCA 130 6 3
3113 - 1504 ± 226 148 ± 142 0.1 - - - - -
3304 Stathmin 700 ± 179 95 ± 67 0.1 STMN1_HUMAN STMN1 85 5 1
3507 - 2247 ± 768 6225 ± 2081 2.8 - - - - -
3514 UMP-CMP kinase 721 ± 148 240 ± 243 0.3 KCY_HUMAN CMPK1 100 5 2
4704 Serum albumin 6705 ± 611 3282 ± 1123 0.5 ALBU_HUMAN ALB 74 4 1
4802 Gelsolin 743 ± 239 355 ± 192 0.5 GELS_HUMAN GSN 178 17 2
4901 Neutral alpha-glucosidase AB 577 ± 178 153 ± 69 0.3 GANAB_HUMAN GANAB 304 23 3
5601 Heat-shock protein beta-1 680 ± 70 517 ± 75 0.8 HSPB1_HUMAN HSPB1 128 3 1
5801 Delta(3,5)-delta(2,4)-dienoyl-CoAisomerase, mitochondrial 980 ± 40 1368 ± 230 1.4 ECH1_HUMAN ECH1 200 10 3
6105 Ubiquitin-like protein ISG15 2519 ± 237 884 ± 473 0.4 ISG15_HUMAN ISG15 80 4 1
6202 Alpha-enolase 9861 ± 410 7341 ± 1801 0.7 ENOA_HUMAN ENO1 499 23 3
7112 - 1293 ± 155 232 ± 131 0.2 - - - - -
7305 Serine hydroxymethyltransferase, mitochondrial 718 ± 113 308 ± 93 0.4 GLYM_HUMAN SHMT2 277 17 2
7803 Elongation factor 2 511 ± 90 181 ± 92 0.4 EF2_HUMAN EEF2 304 22 3
7804 Elongation factor 2 811 ± 236 405 ± 128 0.5 EF2_HUMAN EEF2 307 26 3
8404 t-complex protein 1 subunit delta 543 ± 163 272 ± 112 0.5 TCPD_HUMAN CCT4 158 12 3
8802 Voltage-dependent anion-selectivechannel protein 1 2319 ± 695 3487 ± 162 1.5 VDAC1_HUMAN VDAC1 111 8 1









Figure 1. Protein interaction network for significant different proteins after exposure to hierridin B in









Figure 2. Biological processe (BP) altered by hier idin t color indicates an increase,
while red color a decr ase of BP.
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2.2. mRNA Expression of Target Genes
The mRNA expression of target genes involved in apoptosis (BCL2-associated agonist of cell
death, BAD; tumor necrosis factor superfamily, member 10, TRAIL), cell cycle (cyclin B1, CCNB1;
cyclin E1, CCNE; cyclin-dependent kinase inhibitor 1A, P21CIP) and mitochondria regulation
(voltage-dependent anion channel 1, VDAC), tumor survival (serine hydroxymethyl transferase 2,
SHMT2), and proliferation (vasoactive intestinal peptide receptor 1, VIPR) were analyzed by real-time
PCR using a multiple reference gene normalization approach [16]. CCNB1 and CCNE decreased its
mRNA expression two-fold in response to hierridin B, while P21CIP increased 10-fold (Figure 3).
The mRNA expression of VDAC increased 1.5-fold, while VIPR decreased two-fold (Figure 3).
BAD, TRAIL, and SHMT2 mRNA levels did not show any significant alterations.
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performed  using  CellProfiler  software  and,  in  total,  160  parameters were measured.  Figure  5A 
demonstrates  the  recognition  of  cellular  structures  by CellProfiler. Principal  component  analysis 
discriminated between DMSO (solvent control, 1%) and hierridin B treatment (100.2 μM), majorly by 
principal  component  1  (PC1),  Figure  5B.  Factors  that  contributed  mainly  (>0.85)  to  PC1  were 
3. Relative mRNA xpression in the HT-29 de carcinoma cell line in response to
hierridin B exposure. Data are presented as box-whi ker plots (box: 25%–75% p rcen ile, outer bars:
100% percen ile without outliers, inner bar: median, cross: mean). The mRNA expression was
n rmalized to the geo trical mean of ribosomal protein L8 (RPL8) and hypoxanthine
( ). Statistical diff rences are indicated by asterisks; * = p < 0.05, ** = p < 0.01,
*** = p < 0.001.
. . l resce ce icr sc l sis
fluorescence microsc py analyses demonstrated a strong effect of hierridin B on mitochondria
in the HT-29 cells, stained with Hoechst 3342 (nucleus), F-actin 488 (cytoplasm), and MitoTracker CMX
ROS (mitochondria, Figure 4). The exposure to hierridin B resulted in a substantial lower staining of
mitochondria. An automated quantification of cytoplasm and mitochondria was performed using
C llProfiler softwar and, in total, 160 parameters were measur d. Figure 5A demonstrates the
recognition of cellular structures by CellProfiler. Principal comp nent analysis discriminated between
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DMSO (solvent control, 1%) and hierridin B treatment (100.2 µM), majorly by principal component 1
(PC1), Figure 5B. Factors that contributed mainly (>0.85) to PC1 were mitochondrial-related






RadialDistribution_RadialCV_MaskedRed_9 of 10), while cytoplasm-related parameters
(Texture_AngularSecondMoment_10_0, Texture_AngularSecondMoment_10_135,
Texture_AngularSecondMoment_10_45, Texture_AngularSecondMoment_10_90,
Texture_Entropy_10_135, Texture_Entropy_10_45, Texture_Entropy_10_90, Texture_SumAverage_10_0,
Texture_SumAverage_10_135, Texture_SumAverage_10_45, Texture_SumAverage_10_90,
Texture_SumEntropy_10_0, Texture_SumEntropy_10_135, Texture_SumEntropy_10_45,
Texture_SumEntropy_10_90) contributed mainly (>0.85) to PC2. Two parameters with a high
contribution to PC1 were chosen for statistical analyses (Figure 5C), and the mean radius and intensity
of the mitochondria were significantly decreased by hierridin B exposure compared to DMSO.
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Figure 4. Overlay of three fluorescent channels (blue, nucleus, Hoechst 33342; green, cytoplasm,
acti-stain 488; red, mitochondria, MitoTracker CMXROS) from HT-29 colon adenocarcinoma cells
exposed to solvent control (DMSO) and hierridin B. Scale bar corresponds to 20 µm.
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of  nucleus,  cytoplasm,  and  mitochondria  demonstrated  a  dramatic  decrease  in  mitochondrial 
staining. Since VDAC1  is  involved  in  the  formation of mitochondrial pores,  it  is  likely  that  lower 
mitochondrial staining is related to an alteration of mitochondrial channel activities. The fluorescent 
probe  MitoTracker  CMX  ROS  is  a  live  stain  that  is  oxidized  in  the  cells,  thiol‐conjugated  in 
mitochondria  and,  thus,  indicative  of  active  mitochondria.  Lower  activity  of  mitochondria,  as 
revealed by lower staining of a MitoTracker fluorescent probe, was consistent with the opening of 
the mitochondrial  permeability  transition  pore  (calcein AM  staining)  and  loss  of mitochondrial 
membrane  potential  (JC‐1  staining),  as  described  in  photoactivated  Lonicera  japonica  induced 
apoptosis  in human  lung  cancer  cells  [25]. By using  the  same methodology,  retinoic  acid  and  a 
vitamin D analogue  reduced  the mitochondrial membrane potential and altered  the cell cycle by 
increasing  the  apoptotic  cell  fraction  of  hepatic  cancer  cells  [26].  In  our  study,  the  automated 
Figure 5. (A) Fluorescent images (blue, nucleus; green, cytoplasm; red, mitochondria) and automated
analysis by CellProfiler software; (B) principal component analysis of 160 parameters (object intensity,
object radial distribution, size and shape of objects, and texture) from cytoplasm and mitochondria
quantified by CellProfiler. Principal component 1 (PC1) discriminated between DMSO (solvent control,
1%) and hierridin B treatment. Factors that mainly contributed to the (PC1) were mitochondrial
parameters, while cytoplasm parameters mainly contributed to PC2; and (C) detailed analysis of
two mitochondrial parameters, area shape mean radius and fluorescence mean intensity. Data are
represented as box-whisker plots, and statistical differences are indicated by asterisks (*** = p < 0.001,
Mann-Whitney U-test).
3. Discussion
Cyanobacteria have a huge potential as a source of bioactive compounds relevant for the treatment
of human diseases. The most famous example is brentuximab vedotin, which targets CD30 and
microtubules, and is used for the treatment of malignant lymphoma after approval by the Federal Drug
Agency [17]. Currently, 16 compounds derived from cyanobacteria are in different phases of clinical
trials for the treatment of cancer [18]. Already-characterized modes of actions of bioactive compounds
from cyanobacteria are very diverse and include classical anticancer targets, as microtubulin and
actin, or non-classical targets, as histone deacetylases and proteasome [15]. Our own lab identified
bioactive fractions of different marine cyanobacterial strains that demonstrated the potential to induce
cytotoxicity via different molecular mode of actions on colon carcinoma cells [13]. Hierridin B was
isolated from the cyanobacterium Cyanobium sp. LEGE06113 and showed selective cytotoxicity towards
the colon adenocarcinoma cell line HT-29 [14]. In this study, the presented data indicated two possible
main interactions of hierridin B with colon carcinoma cells: (1) disturbance of mitochondrial function;
and (2) cell cycle arrest.
Proteomics analysis revealed a significant increase of VDAC1 protein, which was confirmed
by significant increased mRNA expression of VDAC1, analyzed by real-time PCR. VDAC1 is
a mitochondrial protein in the outer mitochondrial membrane at the crossroad of cellular metabolism
and cell death, and is important for mitochondrial channels regulating permeability, organ volume,
and apoptosis [19]. VDAC1 oligomerization forms a central pore, being regarded as a key protein
for mitochondria-mediated apoptosis [20]. VDAC1 is an important target for cancer therapies and
some small molecule drugs were found to target the upregulation of VDAC1, as prednisolone [21],
cisplatin, [22] or arbutin [23] in different cancer cell lines. A hypothetical model suggests that
an increase in Ca2+ enhances VDAC1 transcription, and that the resulting increase in VDAC1
protein promotes its oligomerization that in turn leads to cytochrome c release and subsequent
apoptosis [19,24].
In accordance to the alterations of VDAC1, the analysis of HT-29 cells with fluorescence staining
of nucleus, cytoplasm, and mitochondria demonstrated a dramatic decrease in mitochondrial staining.
Since VDAC1 is involved in the formation of mitochondrial pores, it is likely that lower mitochondrial
staining is related to an alteration of mitochondrial channel activities. The fluorescent probe
MitoTracker CMX ROS is a live stain that is oxidized in the cells, thiol-conjugated in mitochondria and,
thus, indicative of active mitochondria. Lower activity of mitochondria, as revealed by lower staining
of a MitoTracker fluorescent probe, was consistent with the opening of the mitochondrial permeability
transition pore (calcein AM staining) and loss of mitochondrial membrane potential (JC-1 staining),
as described in photoactivated Lonicera japonica induced apoptosis in human lung cancer cells [25].
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By using the same methodology, retinoic acid and a vitamin D analogue reduced the mitochondrial
membrane potential and altered the cell cycle by increasing the apoptotic cell fraction of hepatic cancer
cells [26]. In our study, the automated quantification of cytoplasm and mitochondrial parameter
revealed that PCA discriminated between hierridin B treated cells and the solvent control, particularly
with respect to the mitochondrial parameters as reduced mitochondrial size and fluorescence intensity,
which indicated a loss of mitochondrial activity and function. However, general caution is needed with
the interpretation of fluorescent probes, since some anticancer agents were described to quench the
fluorescent signal without true transmembrane potential changes [27]. Still, structural motifs described
to be responsible for quenching (adamantyl moieties, p-aminobenzoic acid moieties) are not found in
hierridin B. Further experiments using electrophysiology of mitochondrial membrane potential would
be needed to confirm the suggested loss of mitochondrial membrane potential.
Interestingly, VDAC1-interacting proteins belong to the cytoskeleton proteins (actins, tubulins),
which regulate the movement of mitochondria along the cytoskeleton within the cell or the interaction
of other organelles with the mitochondria. In our proteomic data, several cytoskeleton proteins had
their levels decreased by the hierridin B treatment, such as GSN, TCPD, TBCA, HSPB1, and STMN1.
GSN is a Ca2+ dependent actin-regulatory protein and inhibits VDAC1 channel activities [19].
STMN1 is involved in the mitotic spindle organization, and a knock-down of STMN1 by gene
silencing increased the sensitivity towards anti-microtubule drugs and led to a cell-cycle arrest at
G2/M phase [28,29]. TBCA is needed for the correct folding of β-tubulin, and gene silencing of TBCA
resulted in an altered microtubule cytoskeleton, cell cycle arrest in the G1/S phase and cell death [30].
STMN1 and TBCA were strongly decreased in our study (both 10-fold), which may provide a link to
the observed alterations of mRNA expression of cell cycle genes.
The reduced mRNA expression of CCNE and CCNB1 (both two-fold), and increased mRNA
expression of P21CIP (10-fold) in our study indicated a general cell-cycle arrest, with known functions
of CCNE for G1/S transition, of CCNB1 for G2/M transition and P21CIP for cell cycle checkpoints at
G1/S and G2/M [31]. Inhibition of cell cycle progression is a common mechanism for anticancer drugs.
A novel anthraquinone derivative arrested the cell cycle of HT29 colon carcinoma cells at the S phase
and G2/M transition independent of P53 [32]. A low-molecular weight fucosylated chondroithin
sulfate isolated from a sea cucumber induced a cell cycle arrest via increased P21CIP expression [33].
Several compounds isolated from cyanobacteria led to G2/M phase arrest (dolastatin 10, dolastatin 15)
or G1/S arrest (calothrixin B, apratoxin A) as reviewed in [11]. In accordance to the data indicating
cell cycle arrest, VIPR mRNA expression was decreased two-fold, which suggested a reduced cell
proliferation, as described in non-small lung cancer cells [34].
Many proteomes and transcriptomes of cancer cell lines are available in publically available
databases. We evaluated quantitative expression differences reported in those databases regarding the
potential main targets of hierridin B effects on HT29 cells, which may be able to explain a different
selectivity towards hierridin B exposure. The Human Protein Atlas (http://www.proteinatlas.org/)
and NCI-60 proteome database (http://129.187.44.58:7070/NCI60/) do not provide relevant
quantitative differences in various cancer cell lines for these targets. From the Cancer Cell Encyclopedia
(http://portals.broadinstitute.org/ccle/home), a dataset (GEO Accession: GSE36133) is available
containing comparative microarrray data across cancer cell lines, but expression differences do
not justify a different selectivity. In the Colorectal Cancer Atlas (http://www.colonatlas.org/),
sequence variants are described for VDAC1 and STMN1 in HT29 and RKO cells. A sequence variance
for VDAC1 in HT29 cells is at a splice site (p.G23_splice), while a sequence variance for STMN1 in RKO
cells is a stop gain (c.28A > C). Further studies will be needed to explain the selectivity of hierridin B
in HT29 cells.
In summary, the exposure of HT-29 carcinoma cells to hierridin B induced significant changes in
VDAC1 mRNA expression and protein content. Fluorescence microscopy and automated quantification
of mitochondria by CellProfiler demonstrated that mitochondrial activity was decreased. The lower
protein level of interacting cytoskeleton proteins (STMN1, TBCA) provided a link to the altered cell
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cycle genes (CCNE, CCNB1, P21CIP) and lower cell proliferation (VIPR). Therefore, hierridin B is
a marine cyanobacterial metabolite that likely targets mitochondrial function.
4. Materials and Methods
4.1. Cyanobacteria Culture and Isolation of Hierridin B
The cyanobacterial strain Cyanobium sp. LEGE06113 was isolated from the Portuguese coast and is
maintained in the Blue Biotechnology and Ecotoxicology Culture Collection [35] at the Interdisciplinary
Centre of Marine and Environmental Research (CIIMAR/CIMAR), Porto, Portugal. The culture
conditions of this cyanobacterium, subsequent isolation and purification of hierridin B were described
in [14], and yielded 240 µg of isolated hierridin B available for the presented work.
4.2. HT-29 Assays
The colon adenocarcinoma cell line HT-29 is from human origin and was obtained from the
American Type Culture Collection (ATCC) and cultured as described in [12]. Briefly cells were
cultured in DMEM Glutamax medium (Dulbecco’s Modified Eagle Medium DMEM GlutaMAX™),
supplemented with 10% (v/v) fetal bovine serum, 1% of penicillin-streptomycin (Pen-Strep 100 IU/mL
and 10 mg/mL, respectively) and 0.1% fungicide Amphotericin B (250 µg/mL). Cells were
maintained in a humidified incubator at 37 ◦C, with 5% CO2. The IC50 value of hierridin B on
the HT-29 cell line was 100.2 µM or 36.4 µg/mL [14], and this concentration was used for mRNA
expression, proteomics and fluorescent microscopy analysis. Cells were seeded in 24-well plates at
a concentration of 1.3 × 105 cells/cm2 and exposed for 48 h to hierridin B. For mRNA expression assays,
proteomics and fluorescent microscopy six, four, and three replicates were prepared, respectively.
4.3. Protein Extraction and Two-Dimensional Gel Electrophoresis (2DGE)
Protein extraction from the cell pellet was performed by adding 80 µL solubilisation buffer
(urea (7 M), thiourea (2 M), 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate
(CHAPS, 4%, w/v), dithiothreitol (65 mM), and ampholytes (0.8%, v/v, pH 4–7)) on the cell
pellets. After one hour homogenization, solutions were centrifuged at 16,000× g for 20 min
at 4 ◦C. The supernatant was collected, and total protein content determined by the Bradford
method [13]. 2DGE was performed for protein separation following the procedure described in [13].
Two-hundred twenty-five micrograms of protein in a volume of 250 µL solubilizaton buffer were
loaded on 11 cm, pH 3–10 gel strips and separated by isoelectric focusing (IEF) using Protean IEF Cell
(Bio-Rad) and 12% (w/v) acrylamide SDS-PAGE with SE900 Hoefer.
4.4. Gel Staining, Image Acquisition, and Protein Expression Analysis
Gel staining was performed using the Coomassie Blue Colloidal method, gel images were acquired
in the GS-800 calibrated densitometer from Bio-Rad, and protein spots were detected automatically
with the PDQuest 2-D analysis software, according to [13]. The quantitative variations were statistically
evaluated by Student’s t and Mann-Whitney U tests (p ≤ 0.05).
4.5. Protein Identification
Protein identification was performed according to the method described by [36]. Briefly,
protein spots were excised from gels, reduced with dithiothreitol (DTT, Sigma, St. Louis, MO,
USA), alkylated with iodacetamide (Sigma) and subjected to in-gel digestion using trypsin
(Promega, Madison, WI, USA). The resulting tryptic peptides were desalted and concentrated using
reversed-phase C18 10 µL tips (Pierce, Thermo Fisher Scientific, Waltham, MA, USA), according to the
manufacturer’s instructions. The peptides were eluted directly onto the MALDI plate in duplicates
using the matrix alpha-cyano-4-hydroxycinnamic acid (7–8 mg/mL) prepared in acetonitrile (50%, v/v)
and trifluoroacetic acid (0.1%, v/v). Peptide mass spectra were obtained on a MALDI-TOF/TOF
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mass spectrometer (4800 Proteomics Analyzer, Applied Biosystems/Life Technologies, Carlsbad, CA,
USA) in the positive ion reflector mode. Spectra were obtained in the mass range between 800 and
4500 Da with ca. 1500 laser shots. For each sample spot, a data dependent acquisition method
was created to select the six most intense peaks, excluding those from the matrix, trypsin autolysis,
or acrylamide peaks, for subsequent MS/MS data acquisition. Spectra were processed and analyzed by
the Global Protein Server Workstation (Applied Biosystems), which uses internal MASCOT software
(v2.1.0 Matrix Science, London, UK) on searching the peptide mass fingerprints and MS/MS data.
The Swiss-Prot non-redundant protein sequence database (October 2014) was used for all searches
under taxonomy Homo sapiens. Database search parameters are as follows: carbamidomethylation
and propionamide of cysteine as a variable modification, as well as oxidation of methionine, and the
allowance for up to two missed tryptic cleavages. The peptide mass tolerance was 25 ppm and the
fragment ion mass tolerance was 0.3 Da. Positive identifications were accepted up to a 95% confidence
level. Spots with no identification were repeated in duplicates using the same conditions. The free
online software STRING [37] was used for evaluation of protein interaction networks between the
solvent control and the hierridin B exposure groups. Protein interaction analysis regarding their
biological processes were performed with ClueGo + CluePedia [38].
4.6. Real-Time Analysis
For real-time PCR, two reference genes (RPL8, HPRT1) and four target genes (CCNB1, CCNE,
P21CIP, BAD) for apoptosis and cell cycle were selected, as described in [13]. Furthermore,
real-time PCR assays were developed for target genes involved in mitochondrial regulation (VDAC),
tumor survival (SHMT2), as apoptosis (TRAIL), and cell proliferation (VIPR) (Table 2). RNA was
extracted using the Nucleospin RNA XS Kit (Macherey-Nagel, Dueren, Germany), quantified with the
Qubit Fluorometer (Invitrogen, Carlsbad, CA, USA) according to the manufacturer instruction and
RNA quality was assessed by 1% gel agarose electrophoresis. Transcription of RNA into cDNA was
performed by reverse transcription (RT) using the iScript Reverse Transcription Supermix Kit (BioRad).
One microgram of total RNA was reverse-transcribed in a 20 µL reaction (5 min at 25 ◦C, 30 min at
42 ◦C and 5 min at 85 ◦C), and cDNA was stored at −20 ◦C.
Real-time PCR analyses were performed using the iQ5 real-time PCR machine (Bio-Rad). The final
reaction volume was 20 µL containing 1xiQ SYBR Green Supermix (Bio-Rad), each 200 nM forward
and reverse primer, and 2 µL cDNA sample (1:10 diluted), and samples were run as described in [13].
Table 2. Primers selected for mRNA expression as target genes.




















105.7% 0.992 57 ◦CR: CTGCTGTCACTCTTCCTG
4.7. Fluorescence Microscopy
Cells were seeded on glass slides inserted into a 24-well plate at a concentration of
1.3 × 105 cells/cm2 exposed for 48 h to hierridin B or solvent control (DMSO) as described
above. Three replicate wells were used for the control group (DMSO) and two replicate wells
for hierridin B, due to limitations in compound availability. Cells were stained for 20 min at
37 ◦C with 5 µg/mL Hoechst 33342 (HO, nucleus; Sigma) and 250 nM MitoTracker RedCMXRos
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(mitochondria; Life Technologies) and then fixed in 4% paraformaldehyde. Following, cells were
permeabilized with 0.5% Triton X-100 in PBS and stained with 100 nM Actin-stain 488 phalloidin
(actin fibers, Cytoskeleton Inc., Denver, CO, USA) for 30 min at room temperature in the dark. The glass
slides were then mounted on microscope slides with Fluoromount (Sigma), before being visualized on
a fluorescence microscope (Olympus BX-71). Eight to 13 images were taken randomly per replicate at
a magnification of 400× with fixed exposure times (HO: 200 ms, MitoTracker: 714 ms, Actin: 50 ms),
which summed up to 29 images for DMSO group, and 24 images for the hierridin B group. Images were
analyzed with the CellProfiller software [39] and, in total, 160 parameters related to cytoplasm and
mitochondria were automatically quantified. The following modules were included in the pipeline:
object intensity (19 parameters), object radial distribution (three parameters, in 10 bins each), size and
shape of objects (18 parameters), and texture (13 parameters). A complete list of parameters can be
found in the manual of CellProfiler (available at [40]). Values of parameters from individual cells on
each image were averaged, and the mean value per image of the corresponding parameter was used
for further statistical analyses.
4.8. Statistics
For the real-time PCR data, the Kolmogorov-Simirnov test was used to analyze the normality
distribution, and the Bartlett’s test for equal variances. If these conditions were met, one-way ANOVA
was performed followed by Tukey’s post-hoc test. If conditions for parametric tests were not
fulfilled, non-parametric tests, Kruskal-Wallis, and Dunn’s post-hoc test were used. Differences were
considered significant when p≤ 0.05. For the fluorescence microscopy data quantified with CellProfiller,
principal component analysis was performed for the 160 parameters of cytoplasm and mitochondria.
Factors were Kaiser normalized and Varimax rotated. Variables that contributed >0.85 to the factor
loadings of PC1 or PC2 were considered as important.
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